Literature DB >> 17395714

Molecular basis of MAPK-activated protein kinase 2:p38 assembly.

Andre White1, Christopher A Pargellis, Joey M Studts, Brian G Werneburg, Bennett T Farmer.   

Abstract

p38 MAPK and MAPK-activated protein kinase 2 (MK2) are key components of signaling pathways leading to many cellular responses, notably the proinflammatory cytokine production. The physical association of p38alpha isoform and MK2 is believed to be physiologically important for this signaling. We report the 2.7-A resolution crystal structure of the unphosphorylated complex between p38alpha and MK2. These protein kinases bind "head-to-head," present their respective active sites on approximately the same side of the heterodimer, and form extensive intermolecular interactions. Among these interactions, the MK2 Ile-366-Ala-390, which includes the bipartite nuclear localization signal, binds to the p38alpha-docking region. This binding supports the involvement of noncatalytic regions to the tight binding of the MK2:p38alpha binary assembly. The MK2 residues 345-365, containing the nuclear export signal, block access to the p38alpha active site. Some regulatory phosphorylation regions of both protein kinases engage in multiple interactions with one another in this complex. This structure gives new insights into the regulation of the protein kinases p38alpha and MK2, aids in the better understanding of their known cellular and biochemical studies, and provides a basis for understanding other regulatory protein-protein interactions involving signal transduction proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395714      PMCID: PMC1851067          DOI: 10.1073/pnas.0701679104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

Review 2.  MAPKAP kinases - MKs - two's company, three's a crowd.

Authors:  Matthias Gaestel
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

3.  Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme.

Authors:  Kathryn W Underwood; Kevin D Parris; Elizabeth Federico; Lidia Mosyak; Robert M Czerwinski; Tania Shane; Meggin Taylor; Kristine Svenson; Yan Liu; Chu-Lai Hsiao; Scott Wolfrom; Michelle Maguire; Karl Malakian; Jean-Baptiste Telliez; Lih-Ling Lin; Ronald W Kriz; Jasbir Seehra; William S Somers; Mark L Stahl
Journal:  Structure       Date:  2003-06       Impact factor: 5.006

4.  Characterization of an autoinhibitory domain in human mitogen-activated protein kinase-activated protein kinase 2.

Authors:  Y L Zu; Y Ai; C K Huang
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

Review 5.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

6.  Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125.

Authors:  Yong-Seok Heo; Su-Kyoung Kim; Chang Il Seo; Young Kwan Kim; Byung-Je Sung; Hye Shin Lee; Jae Il Lee; Sam-Yong Park; Jin Hwan Kim; Kwang Yeon Hwang; Young-Lan Hyun; Young Ho Jeon; Seonggu Ro; Joong Myung Cho; Tae Gyu Lee; Chul-Hak Yang
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

7.  MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.

Authors:  Georg Stoecklin; Tiffany Stubbs; Nancy Kedersha; Stephen Wax; William F C Rigby; T Keith Blackwell; Paul Anderson
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

8.  Interleukin (IL)-6 signaling leads to phosphorylation of the small heat shock protein (Hsp)27 through activation of the MAP kinase and MAPKAP kinase 2 pathway in monocytes and monocytic leukemia cells.

Authors:  C Belka; A Ahlers; C Sott; M Gaestel; F Herrmann; M A Brach
Journal:  Leukemia       Date:  1995-02       Impact factor: 11.528

9.  Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells.

Authors:  M Allen; L Svensson; M Roach; J Hambor; J McNeish; C A Gabel
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

Authors:  Christopher Pargellis; Liang Tong; Laurie Churchill; Pier F Cirillo; Thomas Gilmore; Anne G Graham; Peter M Grob; Eugene R Hickey; Neil Moss; Susan Pav; John Regan
Journal:  Nat Struct Biol       Date:  2002-04
View more
  46 in total

1.  Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Authors:  Zachary B Hill; B Gayani K Perera; Simeon S Andrews; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2011-12-22       Impact factor: 5.100

2.  The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor.

Authors:  Sergiy Kostenko; Mahmud Tareq Hassan Khan; Ingebrigt Sylte; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

3.  Molecular mechanism by which palmitate inhibits PKR autophosphorylation.

Authors:  Hyunju Cho; Shayantani Mukherjee; Pratheeba Palasuberniam; Lisa Pillow; Betul Bilgin; Catherine Nezich; S Patrick Walton; Michael Feig; Christina Chan
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

4.  MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells.

Authors:  Jessica Schwermann; Chozhavendan Rathinam; Maria Schubert; Stefanie Schumacher; Fatih Noyan; Haruhiko Koseki; Alexey Kotlyarov; Christoph Klein; Matthias Gaestel
Journal:  EMBO J       Date:  2009-04-16       Impact factor: 11.598

5.  Structural basis for the regulation of the mitogen-activated protein (MAP) kinase p38α by the dual specificity phosphatase 16 MAP kinase binding domain in solution.

Authors:  Ganesan Senthil Kumar; Heiko Zettl; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

Review 6.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

7.  The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding.

Authors:  Ahmet Bakan; Ivet Bahar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

8.  Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.

Authors:  Toshio Yoshizawa; Deepa Hammaker; David L Boyle; Maripat Corr; Richard Flavell; Roger Davis; Georg Schett; Gary S Firestein
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

Review 9.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

10.  P38 mitogen-activated protein kinase activity is required during mitosis for timely satisfaction of the mitotic checkpoint but not for the fidelity of chromosome segregation.

Authors:  Kyunghee Lee; Alison E Kenny; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.